News › Industry News, News

Allergan Completes Vitae Tender Offer

November 1, 2016

Allergan completed their tender offer to purchase all outstanding shares of Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company.
A tender offer occurs when an acquiring company offers to buy another company’s stock from shareholders at a specified price. The next step is a merger. Allergan offered to purchase all outstanding shares of Vitae for $21.00 per share, in cash, for a total transaction value of approximately $639 million.
Read More >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • 10 Marketing Truths Every Aesthetic Practice Needs to Hear Right Now
    • AI, FDA, PDGF: The Talk of MSS
    • Radiologists Warn that Décolletage Filler May Interfere with Breast Cancer Screening
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical